BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15359828)

  • 21. Antibody- and genome-based identification of recent HCV infection.
    Araujo AC
    Antivir Ther; 2012; 17(7 Pt B):1459-64. PubMed ID: 23322615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
    Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
    Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
    Chevaliez S; Pawlotsky JM
    Clin Liver Dis; 2005 Aug; 9(3):371-82, v. PubMed ID: 16023971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical view of acute hepatitis C].
    Kiyosawa K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):347-52. PubMed ID: 15359819
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HCV RNA testing for early diagnosis of hepatitis C in blood donors--new challenge for transfusion medicine and hepatology].
    Brojer E; Letowska M; Gronowska A; Kubicka-Russel D; Liszewski G; Grabarczyk P; Medyńska J; Mikulska K; Sabliński J
    Pol Merkur Lekarski; 2004 Oct; 17(100):321-5. PubMed ID: 15690692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical management of asymptomatic HCV carriers].
    Nakamura I; Ochiai K; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):396-9. PubMed ID: 15359829
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic assessment of a HCV + patient].
    Buffet C
    Presse Med; 2004 Mar; 33(6):425-6. PubMed ID: 15105790
    [No Abstract]   [Full Text] [Related]  

  • 32. Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation.
    Chiang JC; Lin CY; Wang JH; Kee KM; Chen PF; Chen YD; Tsai LS; Chen TH; Lu SN
    Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):917-23. PubMed ID: 19403151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 34. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory assays for diagnosis and management of hepatitis C virus infection.
    Richter SS
    J Clin Microbiol; 2002 Dec; 40(12):4407-12. PubMed ID: 12454127
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis of occult hepatitis C without the need for a liver biopsy.
    Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V
    J Med Virol; 2010 Sep; 82(9):1554-9. PubMed ID: 20648609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus antibody positivity may not be associated with hepatitis C infection in patients with autoimmune gastritis.
    Soykan I; Yakut M; Keskin O
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):122-3. PubMed ID: 23011039
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple liver lesions in a patient with positive hepatitis C serology and elevated AFP: is it HCC?
    Dwyer JP; Hosking P; Lubel J
    Gastroenterology; 2014 Sep; 147(3):e12-3. PubMed ID: 25064545
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characteristics of each commercially available anti-HCV assay kit used in screening for HCV infection].
    Ishikawa K; Koyama T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):199-207. PubMed ID: 15359793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.